Is this you? Create Your Porfile
Avatar

Christoph Krell

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Christoph Krell is active.

Explore More

Publication

Featured researches published by Christoph Krell.

Archive | 2006

Process for the synthesis of organic compounds

Stephan Abel; Murat Acemoglu; Bernhard Erb; Christoph Krell; Joseph Sclafani; Mark Meisenbach; Mahavir Prashad; Wen-Chung Shieh; Song Xue

Archive | 2008

Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms

Martin James Drysdale; Brian William Dymock; Christoph Krell; Michael Mutz; Holger Petersen; Weijia Zheng

Archive | 2005

Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivatives

Christoph Krell; Hans Hirt

Archive | 2003

Intermediate for the manufacture of valsartan

Hans Hirt; Gottfried Sedelmeier; Christoph Krell

Archive | 2016

PREPARATION OF AND FORMULATION COMPRISING A MEK INHIBITOR

Christoph Krell; Marian Misun; Daniel Niederer; Werner Pachinger; Marie-Christine Wolf; Daniel Zimmermann; Weidong Liu; Peter J. Stengel; Paul Nichols

Transition Metal-Catalyzed Couplings in Process Chemistry: Case Studies from the Pharmaceutical Industry | 2013

Experiences with Negishi Couplings on Technical Scale in Early Development

Murat Acemoglu; Markus Baenziger; Christoph Krell; Wolfgang Marterer

Archive | 2017

preparação e formulação compreendendo um inibidor de mek

Christoph Krell; Daniel Niederer; Daniel Zimmermann; Marian Misun; Marie Wolf; Paul J. Nichols; Peter J. Stengel; Weidong Liu; Werner Pachinger

Archive | 2016

PREPARACIÓN DE UN INHIBIDOR DE MEK Y FORMULACIÓN QUE LO COMPRENDE

Paul J. Nichols; Peter J. Stengel; Weidong Liu; Daniel Zimmermann; Marie Wolf; Werner Pachinger; Daniel Niederer; Marian Misun; Christoph Krell

Archive | 2012

5-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-4-(4-MORPHOLIN-4-YLMETHYL-PHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE MESYLATE, HYDRATES AND POLYMORPHS THEREOF, AND FORMULATIONS COMPRISING THESE FORMS

Martin James Drysdale; Brian William Dymock; Christoph Krell; Michael Mutz; Holger Petersen; Weijia Zheng

Archive | 2006

Processes for the synthesis of 5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine and its intermediates

Stephan Abel; Murat Acemoglu; Bernhard Erb; Christoph Krell; Joseph Sclafani; Mark Meisenbach; Mahavir Prashad; Wen-Chung Shieh; Song Xue

Explore More

Collaboration

Dive into the Christoph Krell's collaboration.

Top Co-Authors
Avatar

Murat Acemoglu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Bernhard Erb

Novartis

View shared research outputs
Top Co-Authors
Avatar

Joseph Sclafani

Novartis

View shared research outputs
Top Co-Authors
Avatar

Mark Meisenbach

Novartis

View shared research outputs
Top Co-Authors
Avatar

Song Xue

Novartis

View shared research outputs
Top Co-Authors
Avatar

Stephan Abel

Novartis

View shared research outputs
Top Co-Authors
Avatar

Wen-Chung Shieh

Novartis

View shared research outputs
Top Co-Authors
Avatar

Mahavir Prashad

University of Bath

View shared research outputs
Top Co-Authors
Avatar

Hans Hirt

Novartis

View shared research outputs
Top Co-Authors
Avatar

Daniel Niederer

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge